News

Searching for compounds with the therapeutic effects of ibogaine but not is toxicity, researchers found two that eased depression and opioid withdrawal in mice.

Researchers found that a small synthetic molecule called Bobcat339 significantly weakened anorexia nervosa—as well as associated anxiety and depressive-like behaviors—in a mouse model, with few side effects.

Kinases are essential for cell signaling. A new study matches kinases to their targets, enabling a deeper understanding of biological processes.

Kinases are essential for cell signaling. A new study matches hundreds of kinases to their targets, enabling a deeper understanding of biological processes.

The 2022 Yale Life Science Pitchfest held on December 8, 2022 featured 31 Yale faculty innovators presenting breakthrough research projects in therapeutics, medical devices, and digital health to a crowd of over 325 people from 120+ companies, including 14 industry judges.

The 2022 Yale Life Science Pitchfest held on December 8, 2022 featured 31 Yale faculty innovators presenting breakthrough research projects in therapeutics, medical devices, and digital health to a crowd of over 325 people from 120+ companies, including 14 industry judges.

In a new study, Yale Cancer Center researchers found molecular explanations for why some lung tumors respond better to certain drugs than others. The research should help improve drug selection for lung cancer patients with different mutations in the EGF receptor, using a precision medicine approach to treatment.

Mark A. Lemmon, PhD, will become chair of the Department of Pharmacology in July 2023.

Q&A with Roy Herbst, MD, PhD, medical oncologist, in recognition of Lung Cancer Awareness Month.